RIVASTIGMINE TARTRATE

Ajanta Pharma Limited🇺🇸 United States

FDA Page

Effective Date: Feb 19, 2018
Approval ID: 3d257f22-b504-4707-9b29-5ce9032667ca
Products: 4 registered
Version: 7

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use RIVASTIGMINE TARTRATE CAPSULES safely and effectively. See full prescribing information for RIVASTIGMINE TARTRATE CAPSULES. RIVASTIGMINE tartrate capsules, for oral use Initial U.S. Approval: 2000

Quick Stats

Total Products4

Labelers2

Label Sections16

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.